163 related articles for article (PubMed ID: 14769134)
21. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
22. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors.
Vandeputte DA; Troost D; Leenstra S; Ijlst-Keizers H; Ramkema M; Bosch DA; Baas F; Das NK; Aronica E
Glia; 2002 Jun; 38(4):329-38. PubMed ID: 12007145
[TBL] [Abstract][Full Text] [Related]
23. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons.
Boutz PL; Stoilov P; Li Q; Lin CH; Chawla G; Ostrow K; Shiue L; Ares M; Black DL
Genes Dev; 2007 Jul; 21(13):1636-52. PubMed ID: 17606642
[TBL] [Abstract][Full Text] [Related]
24. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor differentially regulates low density lipoprotein receptor-related protein gene expression in neoplastic and fetal human astrocytes.
Hussaini IM; Brown MD; Karns LR; Carpenter J; Redpath GT; Gonias SL; Vandenberg SR
Glia; 1999 Jan; 25(1):71-84. PubMed ID: 9888299
[TBL] [Abstract][Full Text] [Related]
26. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of mortalin expression in human brain tumors.
Takano S; Wadhwa R; Yoshii Y; Nose T; Kaul SC; Mitsui Y
Exp Cell Res; 1997 Nov; 237(1):38-45. PubMed ID: 9417864
[TBL] [Abstract][Full Text] [Related]
28. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
Kimura T; Budka H; Soler-Federsppiel S
Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
[TBL] [Abstract][Full Text] [Related]
29. PTB: Not just a polypyrimidine tract-binding protein.
Dai S; Wang C; Zhang C; Feng L; Zhang W; Zhou X; He Y; Xia X; Chen B; Song W
J Cell Physiol; 2022 May; 237(5):2357-2373. PubMed ID: 35288937
[TBL] [Abstract][Full Text] [Related]
30. Differentiation-induced colocalization of the KH-type splicing regulatory protein with polypyrimidine tract binding protein and the c-src pre-mRNA.
Hall MP; Huang S; Black DL
Mol Biol Cell; 2004 Feb; 15(2):774-86. PubMed ID: 14657238
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles.
Rahman L; Bliskovski V; Reinhold W; Zajac-Kaye M
Genomics; 2002 Sep; 80(3):245-9. PubMed ID: 12213192
[TBL] [Abstract][Full Text] [Related]
32. Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner.
Wang C; Norton JT; Ghosh S; Kim J; Fushimi K; Wu JY; Stack MS; Huang S
J Biol Chem; 2008 Jul; 283(29):20277-87. PubMed ID: 18499661
[TBL] [Abstract][Full Text] [Related]
33. RNAi-mediated PTB depletion leads to enhanced exon definition.
Wagner EJ; Garcia-Blanco MA
Mol Cell; 2002 Oct; 10(4):943-9. PubMed ID: 12419237
[TBL] [Abstract][Full Text] [Related]
34. Regulation of retention of FosB intron 4 by PTB.
Marinescu V; Loomis PA; Ehmann S; Beales M; Potashkin JA
PLoS One; 2007 Sep; 2(9):e828. PubMed ID: 17786200
[TBL] [Abstract][Full Text] [Related]
35. Identification of PSF, the polypyrimidine tract-binding protein-associated splicing factor, as a developmentally regulated neuronal protein.
Chanas-Sacré G; Mazy-Servais C; Wattiez R; Pirard S; Rogister B; Patton JG; Belachew S; Malgrange B; Moonen G; Leprince P
J Neurosci Res; 1999 Jul; 57(1):62-73. PubMed ID: 10397636
[TBL] [Abstract][Full Text] [Related]
36. Regulation of alternative splicing by PTB and associated factors.
Spellman R; Rideau A; Matlin A; Gooding C; Robinson F; McGlincy N; Grellscheid SN; Southby J; Wollerton M; Smith CW
Biochem Soc Trans; 2005 Jun; 33(Pt 3):457-60. PubMed ID: 15916540
[TBL] [Abstract][Full Text] [Related]
37. Differential nuclear localization and nuclear matrix association of the splicing factors PSF and PTB.
Meissner M; Dechat T; Gerner C; Grimm R; Foisner R; Sauermann G
J Cell Biochem; 2000 Jan; 76(4):559-66. PubMed ID: 10653975
[TBL] [Abstract][Full Text] [Related]
38. Polypyrimidine tract binding protein and Notch1 are independently re-expressed in glioma.
Cheung HC; Corley LJ; Fuller GN; McCutcheon IE; Cote GJ
Mod Pathol; 2006 Aug; 19(8):1034-41. PubMed ID: 16729017
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.
He X; Pool M; Darcy KM; Lim SB; Auersperg N; Coon JS; Beck WT
Oncogene; 2007 Jul; 26(34):4961-8. PubMed ID: 17310993
[TBL] [Abstract][Full Text] [Related]
40. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy.
Recht L; Torres CO; Smith TW; Raso V; Griffin TW
J Neurosurg; 1990 Jun; 72(6):941-5. PubMed ID: 2159987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
